MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.87 +0.42 (+3.67%)
As of: Sep 30, 2026 · 3:26 PM EDT

MoonLake Immunotherapeutics (MLTX) Total Non-Current Liabilities (2020 - 2026)

Updated

MoonLake Immunotherapeutics' Total Non-Current Liabilities came in at $100.36 million for Q2 2026, up 34.2% from $74.79 million a year earlier and up 0.1% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, MoonLake Immunotherapeutics' Total Non-Current Liabilities was $74.47 million.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $2.08 million in FY2024 (-32.6%), $3.08 million in FY2023 (+649.9%), $411,157 in FY2022 (+71.4%) and $239,860 in FY2021 (-99.8%).
  • The Q2 2026 figure represents the highest quarterly Total Non-Current Liabilities since Q1 2022.
  • Year-over-year, Total Non-Current Liabilities increased in three of the last four quarters, with growth averaging 228.9%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q3 2024 (growth of 879.8%), and the weakest in Q3 2022 (a decline of 100.0%).
  • Business Quant data shows MLTX's Total Non-Current Liabilities at $100.24 million (Q1 2026), $74.47 million (Q4 2025) and $74.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 MoonLake Immunotherapeutics 974.47 Mn -694.93 Mn - 100.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.36 Mn
Mar 31, 2026 100.24 Mn
Dec 31, 2025 74.47 Mn
Sep 30, 2025 74.78 Mn
Jun 30, 2025 74.79 Mn
Mar 31, 2025 74.70 Mn
Dec 31, 2024 2.08 Mn
Sep 30, 2024 2.63 Mn
Jun 30, 2024 2.56 Mn
Mar 31, 2024 2.82 Mn
Dec 31, 2023 3.08 Mn
Sep 30, 2023 268,483.00
Jun 30, 2023 376,614.00
Mar 31, 2023 405,255.00
Dec 31, 2022 411,157.00
Sep 30, 2022 4,985.00
Jun 30, 2022 18,588.00
Mar 31, 2022 252.45 Mn
Dec 31, 2021 239,860.00
Sep 30, 2021 115.33 Mn
API Access

MoonLake Immunotherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MLTX&period=max&api_key=YOUR_API_KEY